By Chris Wack
Astrana Health shares fell after the healthcare company reported a surprise fourth-quarter loss.
The stock was down 30%, to $24.31, midday Friday after hitting a three-year low of $23.12 earlier in the session. Shares have lost 44% in the past 12 months.
The Alhambra, Calif., company on Thursday said it had a quarterly loss of $7 million, or 15 cents a share, compared with earnings of $12.4 million, or 26 cents a share, in the same quarter last year. Analysts polled by FactSet were looking for earnings of $5.3 million, or 10 cents a share.
Revenue for the quarter was $665.2 million, compared with last year's $353 million and the $617.2 million analysts were looking for.
For 2025, the company is looking for revenue of $2.5 billion to $2.7 billion, compared with the $2.595 billion analysts are forecasting. The guidance includes $15 million in expected costs associated with continued strategic investments in automation and artificial intelligence, as well as continuing and expected integration costs associated with planned acquisitions. It doesn't include contributions from any acquisitions which haven't yet closed.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
February 28, 2025 13:52 ET (18:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.